{
    "references": [
        {
            "bibentry": "Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–86. PMID: 25220842",
            "process_entry": "True",
            "doi": "10.1002/ijc.29210",
            "pmid": "25220842",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Hanahan, D, Weinberg, RA. The hallmarks of cancer. Cell 2000; 100: 57–70. PMID: 10647931",
            "process_entry": "True",
            "doi": "10.1016/s0092-8674(00)81683-9",
            "pmid": "10647931",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Adams, JM, Cory, S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26: 1324–37. PMID: 17322918",
            "process_entry": "True",
            "doi": "10.1038/sj.onc.1210220",
            "pmid": "17322918",
            "pmcid": "PMC2930981",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Vogler, M, Dinsdale, D, Dyer, MJS, Cohen, GM. Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009; 16: 360–7. PMID: 18806758",
            "process_entry": "True",
            "doi": "10.1038/cdd.2008.137",
            "pmid": "18806758",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Soreide, K, Janssen, EA, Korner, H, Baak, JPA. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion and metastasis. J Pathol 2006; 209: 145–56.",
            "process_entry": "True",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Rakashanda, S, Rana, F, Rafiq, S, et al. Role of proteases in cancer: a review. Biotechnol Mol Biol Rev 2012; 7: 90–101.",
            "process_entry": "True",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Zucker, S, Vacirca, J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004; 23: 101–17. PMID: 15000152",
            "process_entry": "True",
            "doi": "10.1023/a:1025867130437",
            "pmid": "15000152",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Nierodzik, ML, Karpatkin, S. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin regulated dormant tumor phenotype. Cancer Cell 2006; 10: 355–62. PMID: 17097558",
            "process_entry": "True",
            "doi": "10.1016/j.ccr.2006.10.002",
            "pmid": "17097558",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Ho, AS, Chen, CH, Cheng, CC, et al. Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers. Oncotarget 2014; 5: 473–80. PMID: 24457622",
            "process_entry": "True",
            "doi": "10.18632/oncotarget.1631",
            "pmid": "24457622",
            "pmcid": "PMC3964222",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Dennis, EA, Cao, J, Hsu, YH, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011; 111: 6130–85. PMID: 21910409",
            "process_entry": "True",
            "doi": "10.1021/cr200085w",
            "pmid": "21910409",
            "pmcid": "PMC3196595",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Luo, C, Zhang, H. The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal cancer. Mediators Inflamm 2017; 2017: 1.",
            "process_entry": "True",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Vulcan, A, Manjer, J, Ohlsson, B. High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study. BMC Cancer 2017; 17: 842–9. PMID: 29233100",
            "process_entry": "True",
            "doi": "10.1186/s12885-017-3874-4",
            "pmid": "29233100",
            "pmcid": "PMC5727949",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Ojo, OA, Afon, AA, Ojo, AB, et al. Inhibitory effects of solvent-partitioned fractions of two nigerian herbs (spondias mombin linn. and mangifera indica L.) on α-amylase and α-glucosidase. Antioxidants 2018; 7: 73.",
            "process_entry": "True",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Li, X, Meng, X, Gao, X, et al. Elevated serum xanthine oxidase activity is associated with the development of type 2 diabetes: a prospective cohort study. Diabetes Care 2018; 41: 88–890. PMID: 29118059",
            "process_entry": "True",
            "doi": "10.2337/dc17-1074",
            "pmid": "29118059",
            "pmcid": "PMC5741151",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Kshirsagar, UA. Recent developments in the chemistry of quinazolinone alkaloids. Org Biomol Chem 2015; 13: 9336–52. PMID: 26278395",
            "process_entry": "True",
            "doi": "10.1039/c5ob01379h",
            "pmid": "26278395",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Tiwary, BK, Pradhan, K, Nanda, AK, Chakraborty, R. Implication of quinazoline-4 (3H)-ones in medicinal chemistry: a brief review. J Chem Biol Ther 2015; 1: 1000104.",
            "process_entry": "True",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Vavsari, VF, Ziarani, GM. Synthesis of 4-quinazolinones by transition metal-catalyzed processes (microreview). Chem Heterocycl Comp 2018; 54: 317–9.",
            "process_entry": "True",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Ghorab, MM, Alsaid, MS, Soliman, AM, Al-Mishari, AA. Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors. J Enzyme Inhib Med Chem 2018; 33: 67–73. PMID: 29098904",
            "process_entry": "True",
            "doi": "10.1080/14756366.2017.1389922",
            "pmid": "29098904",
            "pmcid": "PMC6010119",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Mekala, N, Buddepu, SR, Dehury, SK, et al. A novel strategy for the manufacture of idelalisib: controlling the formation of an enantiomer. RSC Adv 2018; 8: 15863–9.",
            "process_entry": "True",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Seema, R, Pathak Malhotra, V, Nath, R, et al. Synthesis and antihypertensive activity of novel quinazolin-4(3H)-one derivatives. Cent Nerv Syst Agents Med Chem 2014; 14: 34–8. PMID: 25174978",
            "process_entry": "True",
            "doi": "10.2174/1871524914666140825144729",
            "pmid": "25174978",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Al-Omar, MA, El-Azab, AS, El-Obeid, HA, Abdel Hamide, SG. Synthesis of some new 4-(3H)-quinazoline analogs as potential antioxidant agents. J Saudi Chem Soc 2006; 10: 113–30.",
            "process_entry": "True",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Jain, N, Jaiswal, J, Pathak, A, Singour, PK. Synthesis, molecular docking and evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one derivatives for their anticonvulsant activity. Cent Nerv Syst Agents Med Chem 2018; 18: 63–73. PMID: 28056730",
            "process_entry": "True",
            "doi": "10.2174/1871524917666170104142033",
            "pmid": "28056730",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Osarumwense, PO, Edema, MO, Usifoh, O. Synthesis and anti-inflammatory activity of 4(3H)-quinazolinone and its 2-methyl and 2-phenyl-4 (3H)-quinazolinone derivatives. IOSR J Appl Chem 2018; 11: 12–5.",
            "process_entry": "True",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "El-Sayed, NN, Alafeefy, AM, Bakht, MA, et al. Synthesis, antiphospholipase A2, antiprotease, antibacterial evaluation and molecular docking analysis of certain novel hydrazones. Molecules 2016; 21: 1664–80.",
            "process_entry": "True",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "El-Sayed, NN, Al-Balawi, NA, Alafeefy, AM, et al. Synthesis, characterization and antimicrobial evaluation of some thiazole-derived carbamates, semicarbazones, amides and carboxamide. J Chem Soc Pak 2016; 38: 358–68.",
            "process_entry": "True",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Nagase, T, Mizutani, T, Ishikawa, S, et al. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists. J Med Chem 2008; 51: 4780–9. PMID: 18598020",
            "process_entry": "True",
            "doi": "10.1021/jm8003834",
            "pmid": "18598020",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Nagase, T, Mizutani, T, Sekino, E, et al. structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. J Med Chem 2008; 51: 6889–901. PMID: 18841880",
            "process_entry": "True",
            "doi": "10.1021/jm800569w",
            "pmid": "18841880",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Kumar, S, Kaur, H, Singh, I, et al. Synthesis, characterization and biological activity of various substituted quinazolinone derivatives containing dopamine moiety. World J Chem 2009; 4: 195–200.",
            "process_entry": "True",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Kumar, P, Shrivastava, B, Stables, JP, Pandeya, SN. Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one. Eur J Med Chem 2011; 46: 1006–18. PMID: 21306800",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2011.01.009",
            "pmid": "21306800",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Kumar, A, Singh, S, Saxena, AK, Shanker, K. Synthesis of quinazolinyl pyrimidinediones and their anti-inflammatory activity. Indian J Chem 1988; 27B: 443–7.",
            "process_entry": "True",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Kim, H, Lee, HJ, Kim, DP. Integrated one-flow synthesis of heterocyclic thioquinazolinones through serial microreactions with two organolithium intermediates. Angew Chem Int Ed Engl 2015; 54: 1877–80. PMID: 25521442",
            "process_entry": "True",
            "doi": "10.1002/anie.201410062",
            "pmid": "25521442",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "van Zyl, EF. A survey of reported synthesis of methaqualone and some positional and structural isomers. Forensic Sci Int 2001; 122: 142–9. PMID: 11672968",
            "process_entry": "True",
            "doi": "10.1016/s0379-0738(01)00484-4",
            "pmid": "11672968",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Soliman, FSG, Shafik, RM, Elnenaey, EA. Synthesis of methaqualone and its diphasic titration in pure and tablet forms. J Pharm Sci 1978; 67: 411–3. PMID: 641736",
            "process_entry": "True",
            "doi": "10.1002/jps.2600670339",
            "pmid": "641736",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Rajasekaran, S, GopalKrishna, R, Sanjay, PPN, Gurpreet, SS. Synthesis, antibacterial and in vitro antioxidant activity of 2,3-substituted quinazolin-4(3 H)-ones. J Chem Pharm Res 2010; 2: 482–8.",
            "process_entry": "True",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "El-Baih, FEM, Al-Blowy, HAS, Al-Hazimi, HM. Synthesis of some thienopyrimidine derivatives. Molecules 2006; 11: 498–513. PMID: 17971721",
            "process_entry": "True",
            "doi": "10.3390/11070498",
            "pmid": "17971721",
            "pmcid": "PMC6148655",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Dineen, TA, Zajac, MA, Myers, AG. Efficient transamidation of primary carboxamides by in situ activation with N, N-dialkylformamide dimethyl acetals. J Am Chem Soc 2006; 128: 16406–9. PMID: 17165798",
            "process_entry": "True",
            "doi": "10.1021/ja066728i",
            "pmid": "17165798",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Reilly, TJ. The preparation of lidocaine. J Chem Educ 1999; 76: 1557.",
            "process_entry": "True",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Lofgren, NM, Lundquist, BJ Alkyl glycinanilides, Patent 2441498A, USA. 1948.",
            "process_entry": "True",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Salman, AS, Abdel-Aziem, A, Alkubbat, MJ. Design, synthesis of some new thio-substituted imidazole and their biological activity. Am J Org Chem 2015; 5: 57–72.",
            "process_entry": "True",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983; 65: 55–63. PMID: 6606682",
            "process_entry": "True",
            "doi": "10.1016/0022-1759(83)90303-4",
            "pmid": "6606682",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Al-Khayal, K, Alafeefy, A, Vaali-Mohammed, MA, et al. Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration. BMC Cancer 2017; 17: 4–15. PMID: 28049506",
            "process_entry": "True",
            "doi": "10.1186/s12885-016-3005-7",
            "pmid": "28049506",
            "pmcid": "PMC5210304",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Lôbo de Araújo, A, Radvanyi, F. Determination of phospholipase A 2 activity by a colorimetric assay using a pH indicator. Toxicon 1987; 25: 1181–8. PMID: 3433293",
            "process_entry": "True",
            "doi": "10.1016/0041-0101(87)90136-x",
            "pmid": "3433293",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Kunitz, M. Crystalline soyabean trypsin inhibitor: II. General properties. J Gen Physiol 1947; 30: 291–310. PMID: 19873496",
            "process_entry": "True",
            "doi": "10.1085/jgp.30.4.291",
            "pmid": "19873496",
            "pmcid": "PMC2142836",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Subramanian, R, Asmawi, MZ, Sadikun, A. In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 2008; 55: 391–8. PMID: 18511986",
            "process_entry": "True",
            "pmid": "18511986",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Andrade-Cetto, A, Becerra-Jiménez, J, Cardenas, VR. Alfa-glucosidase-inhibiting activity of some Mexican plants used in the treatment of type 2 diabetes. J Ethnopharmacol 2008; 116: 27–32. PMID: 18082348",
            "process_entry": "True",
            "doi": "10.1016/j.jep.2007.10.031",
            "pmid": "18082348",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Bondet, V, Brand-Williams, W, Berset, C. Kinetics and mechanisms of antioxidant activity using the DPPH• free radical method. LWT Food Sci Technol 1997; 30: 609–15.",
            "process_entry": "True",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Zolfagharian, H, Mohajeri, M, Babaie, M. Honey bee venom (Apis mellifera) contains anticoagulation factors and increases the blood-clotting time. J Pharmacopuncture 2015; 18: 7–11.",
            "process_entry": "True",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Wacklin, H. Interfacial mechanism of phospholipase A2: pH-dependent inhibition and ME-B-cyclodextrin activation. Biochemistry 2009; 48: 5874–81. PMID: 19419199",
            "process_entry": "True",
            "doi": "10.1021/bi802280b",
            "pmid": "19419199",
            "xmlid": "CIT0048"
        }
    ],
    "localid": "MED-30821525",
    "doi": "10.1080/14756366.2019.1574780",
    "pmid": "10.1080/14756366.2019.1574780",
    "pmcid": "30821525",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30821525/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,125)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),128,86)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),216,232)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),450,135)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,290)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Several in vitro and in vivo clinical studies have suggested a positive correlation between the activity of certain proteases, such as trypsin5, cathepsin B6, collagenases7, thrombin8, and neutrophil elastase9 and colorectal carcinogenesis, invasion, proliferation, and metastasis.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 5,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,290)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Several in vitro and in vivo clinical studies have suggested a positive correlation between the activity of certain proteases, such as trypsin5, cathepsin B6, collagenases7, thrombin8, and neutrophil elastase9 and colorectal carcinogenesis, invasion, proliferation, and metastasis.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 6,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,290)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Several in vitro and in vivo clinical studies have suggested a positive correlation between the activity of certain proteases, such as trypsin5, cathepsin B6, collagenases7, thrombin8, and neutrophil elastase9 and colorectal carcinogenesis, invasion, proliferation, and metastasis.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,290)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Several in vitro and in vivo clinical studies have suggested a positive correlation between the activity of certain proteases, such as trypsin5, cathepsin B6, collagenases7, thrombin8, and neutrophil elastase9 and colorectal carcinogenesis, invasion, proliferation, and metastasis.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,290)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Several in vitro and in vivo clinical studies have suggested a positive correlation between the activity of certain proteases, such as trypsin5, cathepsin B6, collagenases7, thrombin8, and neutrophil elastase9 and colorectal carcinogenesis, invasion, proliferation, and metastasis.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,237)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),1,168)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),171,133)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "In addition, recent studies have linked the incidence of CRC to certain metabolic syndrome components, especially elevated plasma glucose (type 2 diabetes mellitus)12. Several enzymes are reported to be involved in glucose homeostasis, among them α-amylase, α-glucosidase13, and xanthine oxidase14. Hence, targeting these enzymes has high potential in preventing CRC.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 12,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),171,133)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "In addition, recent studies have linked the incidence of CRC to certain metabolic syndrome components, especially elevated plasma glucose (type 2 diabetes mellitus)12. Several enzymes are reported to be involved in glucose homeostasis, among them α-amylase, α-glucosidase13, and xanthine oxidase14. Hence, targeting these enzymes has high potential in preventing CRC.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,117)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),120,499)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 16,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 17,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 18,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 19,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 20,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 21,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),621,404)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The 3H-quinazolin-4-one scaffold is known to be an important building block of various bioactive natural products15. In addition to this, many marketed drugs or experimental drug candidates incorporate this pharmacophore as part of the overall topography of the molecules16 such as ispinesib, nolatrexed, and raltitrexed (the anticancer agents); afloqualone with sedative and muscle relaxant effects, balaglitazone with antidiabetic activities, proquazone (as non-steroidal anti-inflammatory agent), and elinogrel (as reversible P2Y12 receptor antagonist) which is used for the treatment of acute coronary syndrome. Moreover, several new methodologies have been developed for the synthesis of 4-quinazolinone derivatives either using one pot multicomponent approaches17 or via multistep routes for investigating their pharmacological potential as dual EGFR/HER2 inhibitors18, phosphoinositide 3-kinase inhibitors19, and as antihypertensive20, antioxidant21, anticonvulsant22, and anti-inflammatory23 agents.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[6]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[6]),1,362)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            },
            {
                "n_rp": 24,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            },
            {
                "n_rp": 25,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            },
            {
                "n_rp": 26,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            },
            {
                "n_rp": 27,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            },
            {
                "n_rp": 28,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p[2]),1,104)",
                "containers_title": [
                    "Materials and methods",
                    "Chemistry"
                ],
                "pl_string": "Compounds 3a,b26, 3c27, 3d28, 6a29, 6b30, 13a, 13b, and 15a31 were reported previously.",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 29,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[2]/sec[2]/title/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/title),1,64)",
                "containers_title": [
                    "Materials and methods",
                    "General procedure for the preparation of compounds 5a–c\n32\n\n,\n\n33"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[2]/title/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/title),1,65)",
                "containers_title": [
                    "Materials and methods",
                    "General procedure for the preparation of compounds 5a–c\n32\n\n,\n\n33"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[2]/sec[6]/title/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[6]/title),1,48)",
                "containers_title": [
                    "Materials and methods",
                    "Synthesis of Schiff’s base derivatives (8a–j)\n34"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[2]/sec[16]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[16]/p),1,168)",
                "containers_title": [
                    "Materials and methods",
                    "Synthesis of (2-methyl-4-oxo-4H-quinazolin-3-yl)-carbamic acid isobutyl ester (10)"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[2]/sec[17]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[17]/p),133,69)",
                "containers_title": [
                    "Materials and methods",
                    "Synthesis of (E)-N,N-dimethyl-N′-(2-methyl-4-oxo-4H-quinazolin-3-yl)-formamidine (12)"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[2]/sec[18]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[18]/p),1,314)",
                "containers_title": [
                    "Materials and methods",
                    "Synthesis of 2-(4-chloro-benzylsulfanyl)-6-methyl-3-phenyl-3H-quinazolin-4-one (15a31, 15b) and 2-(4-oxo-3-phenyl-3,4-dihydro-quinazolin-2-ylsulfanyl)-acetamide derivatives (15c–f)"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[2]/p),1,137)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "Cell viability assay"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[4]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[4]/p),1,134)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "Western blotting"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0042",
                "rp_string": "42",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[5]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[5]/p),1,351)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "In vitro evaluation of antiphospholipases activities"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0043",
                "rp_string": "43",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[6]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[6]/p),204,280)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "In vitro evaluation of antiproteases activities"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0044",
                "rp_string": "44",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[7]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[7]/p),1,124)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "In vitro inhibition of α-amylase activity"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0045",
                "rp_string": "45",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[8]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[8]/p),1,215)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "In vitro inhibition of α-glucosidase activity"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[2]/sec[23]/sec[9]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[23]/sec[9]/p),1,209)",
                "containers_title": [
                    "Materials and methods",
                    "Biological evaluation",
                    "In vitro inhibition of xanthine oxidase"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0026",
                "rp_string": "26–28",
                "pl_string": "26–28",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),1,274)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            },
            {
                "n_rp": 43,
                "xref_id": "",
                "pl_string": "26–28",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),1,274)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            },
            {
                "n_rp": 44,
                "xref_id": "",
                "pl_string": "26–28",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),1,274)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0026",
                "rp_string": "26–28",
                "pl_string": "26–28",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),1,274)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[4]),277,150)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[5]),1,301)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ],
                "pl_string": "Refluxing of oxazinones 3a,d with excess hydrazine hydrate in ethanol yielded 3-aminoquinazolinons 6a,b29,30, which were converted to certain novel Schiff bases 8a–jvia condensation with a series of aryl aldehydes 7a–e in absolute ethanol containing catalytic amount of glacial acetic acid34. The structures of the new Schiff’s bases were verified by their IR, 1H NMR, 13C NMR, mass spectroscopic (MS) data, and CHN analyses. The IR spectra of compounds 8a–j indicated disappearance of the stretching bands of the amino groups in 3-aminoquinazolin-4-one derivatives 6a,b. The 1H NMR spectra were characterised by the disappearance of the two-protons singlet signals corresponding to the amino protons of starting materials, which resonated at δ 5.79 and 4.89 ppm, accompanied by emergence of new one-proton singlet signals attributed to azomethine protons (CH = N) at δ 9.41_8.70 ppm range. In addition, the 13C NMR spectra displayed the expected spectral lines for each compound with the signals corresponding to (CH = N) groups resonating at δC 159.10–156.46 ppm.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[5]"
            },
            {
                "n_rp": 48,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[5]),1,301)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ],
                "pl_string": "Refluxing of oxazinones 3a,d with excess hydrazine hydrate in ethanol yielded 3-aminoquinazolinons 6a,b29,30, which were converted to certain novel Schiff bases 8a–jvia condensation with a series of aryl aldehydes 7a–e in absolute ethanol containing catalytic amount of glacial acetic acid34. The structures of the new Schiff’s bases were verified by their IR, 1H NMR, 13C NMR, mass spectroscopic (MS) data, and CHN analyses. The IR spectra of compounds 8a–j indicated disappearance of the stretching bands of the amino groups in 3-aminoquinazolin-4-one derivatives 6a,b. The 1H NMR spectra were characterised by the disappearance of the two-protons singlet signals corresponding to the amino protons of starting materials, which resonated at δ 5.79 and 4.89 ppm, accompanied by emergence of new one-proton singlet signals attributed to azomethine protons (CH = N) at δ 9.41_8.70 ppm range. In addition, the 13C NMR spectra displayed the expected spectral lines for each compound with the signals corresponding to (CH = N) groups resonating at δC 159.10–156.46 ppm.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[5]"
            },
            {
                "n_rp": 49,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[5]),1,301)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ],
                "pl_string": "Refluxing of oxazinones 3a,d with excess hydrazine hydrate in ethanol yielded 3-aminoquinazolinons 6a,b29,30, which were converted to certain novel Schiff bases 8a–jvia condensation with a series of aryl aldehydes 7a–e in absolute ethanol containing catalytic amount of glacial acetic acid34. The structures of the new Schiff’s bases were verified by their IR, 1H NMR, 13C NMR, mass spectroscopic (MS) data, and CHN analyses. The IR spectra of compounds 8a–j indicated disappearance of the stretching bands of the amino groups in 3-aminoquinazolin-4-one derivatives 6a,b. The 1H NMR spectra were characterised by the disappearance of the two-protons singlet signals corresponding to the amino protons of starting materials, which resonated at δ 5.79 and 4.89 ppm, accompanied by emergence of new one-proton singlet signals attributed to azomethine protons (CH = N) at δ 9.41_8.70 ppm range. In addition, the 13C NMR spectra displayed the expected spectral lines for each compound with the signals corresponding to (CH = N) groups resonating at δC 159.10–156.46 ppm.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[5]"
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[7]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[7]),1,221)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[8]),1,414)",
                "containers_title": [
                    "Results and discussion",
                    "Chemistry"
                ]
            }
        ],
        [
            {
                "n_rp": 52,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[2]/sec[3]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/sec[3]/p[1]),343,312)",
                "containers_title": [
                    "Results and discussion",
                    "Biological evaluation",
                    "In vitro evaluation of antiphospholipase A2 (PLA2) and antiproteases activities of the synthesised 3H-quinazolin-4-one derivatives"
                ]
            }
        ]
    ]
}